Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Catherine A. McBain"'
Autor:
Kathryn M. Denecke, Catherine A. McBain, Brock G. Hermes, Sireesh Kumar Teertam, Mehtab Farooqui, María Virumbrales-Muñoz, Jennifer Panackal, David J. Beebe, Bolanle Famakin, Jose M. Ayuso
Publikováno v:
Cells, Vol 11, Iss 15, p 2356 (2022)
Stroke is one of the main causes of death in the US and post-stroke treatment options remain limited. Ischemic stroke is caused by a blood clot that compromises blood supply to the brain, rapidly leading to tissue death at the core of the infarcted a
Externí odkaz:
https://doaj.org/article/57d268607c0c4150aec10d241ecd85b5
Autor:
Catherine A McBain, Mehtab A Farooqui, María Virumbrales-Muñoz, Cristina Sanchez-de-Diego, Sireesh Kumar Teertam, Rebecca Schmitz, Melissa Skala, David J Beebe, Jose M Ayuso
Publikováno v:
Cancer Immunology Research. 10:B01-B01
Immunotherapy is transforming cancer treatment for thousands of patients worldwide. However, treatment response relies on the patients’ immune system, eliciting heterogeneous results. Numerous parameters contribute to immunotherapy response, includ
Autor:
Catherine A McBain, Alex Molassiotis, Lisa Brunton, Rao Gattamaneni, Barbara Wilson, Haseeb Chaudhary
Publikováno v:
European journal of oncology nursing : the official journal of European Oncology Nursing Society. 14(5)
Purpose This study was undertaken to further understand the symptom experience and the impact of symptoms in daily life in people treated for brain tumours. Methods A qualitative prospective longitudinal design was used with 9 people who were intervi
Autor:
Neil G Burnet, Thomas Mee, Simona Gaito, Norman F Kirkby, Adam H Aitkenhead, Carmel N Anandadas, Marianne C Aznar, Lisa H Barraclough, Gerben Borst, Frances C Charlwood, Matthew Clarke, Rovel J Colaco, Adrian M Crellin, Noemie N Defourney, Christina J Hague, Margaret Harris, Nicholas T Henthorn, Kirsten I Hopkins, E Hwang, Sam P Ingram, Karen J Kirkby, Lip W Lee, David Lines, Zoe Lingard, Matthew Lowe, Ranald I Mackay, Catherine A McBain, Michael J Merchant, David J Noble, Shermaine Pan, James M Price, Ganesh Radhakrishna, David Reboredo-Gil, Ahmed Salem, Srijith Sashidharan, Peter Sitch, Ed Smith, Edward AK Smith, Michael J Taylor, David J Thomson, Nicola J Thorp, Tracy SA Underwood, John W Warmenhoven, James P Wylie, Gillian Whitfield
Publikováno v:
Burnet, N G, Mee, T, Gaito, S, Kirkby, N F, Aitkenhead, A H, Anandadas, C N, Aznar, M C, Barraclough, L H, Borst, G, Charlwood, F C, Clarke, M, Colaco, R J, Crellin, A M, Defourney, N N, Hague, C J, Harris, M, Henthorn, N T, Hopkins, K I, Hwang, E, Ingram, S P, Kirkby, K J, Lee, L W, Lines, D, Lingard, Z, Lowe, M, Mackay, R I, McBain, C A, Merchant, M J, Noble, D J, Pan, S, Price, J M, Radhakrishna, G, Reboredo-Gil, D, Salem, A, Sashidharan, S, Sitch, P, Smith, E, Smith, E A, Taylor, M J, Thomson, D J, Thorp, N J, Underwood, T S, Warmenhoven, J W, Wylie, J P & Whitfield, G 2022, ' Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy ', The British journal of radiology, vol. 95, no. 1133, A5, pp. 20211175 . https://doi.org/10.1259/bjr.20211175
Objectives: High-energy Proton Beam Therapy (PBT) commenced in England in 2018 and NHS England commissions PBT for 1.5% of patients receiving radical radiotherapy. We sought expert opinion on the level of provision. Methods: Invitations were sent to